GE HealthCare (Nasdaq: GEHC) announced its latest innovations in radiation oncology to be showcased at the American Society for Radiation Oncology (ASTRO) 2024 conference. The company is presenting several AI-enhanced solutions aimed at improving the radiation therapy workflow:
1. Intelligent Radiation Therapy (iRT): Enables multi-vendor system interoperability and efficiency throughout the care continuum.
2. Revolution™ RT: A wide-bore CT platform for precision radiation therapy simulation.
3. MIM Maestro and Contour ProtégéAI+: Interoperable technologies for AI auto-contouring and improved treatment planning.
4. Prostate Volume Assist: AI software for automated prostate volume measurements.
5. StarGuide™: A digital SPECT/CT system for personalized care decisions in Theranostics.
These innovations aim to streamline workflows, reduce time to treatment, and improve patient outcomes in radiation oncology.
GE HealthCare (Nasdaq: GEHC) ha annunciato le sue ultime innovazioni nell’oncologia radioterapica che saranno presentate alla conferenza della American Society for Radiation Oncology (ASTRO) 2024. L’azienda presenta diverse soluzioni potenziate dall’IA, progettate per migliorare il flusso di lavoro nella terapia radioterapica:
1. Terapia Radioterapica Intelligente (iRT): Consente l’interoperabilità e l’efficienza tra sistemi multi-fornitore lungo tutto il continuum di assistenza.
2. Revolution™ RT: Una piattaforma CT a grande apertura per la simulazione della terapia radioterapica di precisione.
3. MIM Maestro e Contour ProtégéAI+: Tecnologie interoperabili per il contouring automatico con IA e una pianificazione del trattamento migliorata.
4. Prostate Volume Assist: Software IA per misurazioni automatiche del volume prostatico.
5. StarGuide™: Un sistema SPECT/CT digitale per decisioni di cura personalizzate in Theranostics.
Queste innovazioni mirano a snellire i flussi di lavoro, ridurre i tempi di trattamento e migliorare i risultati per i pazienti nell’oncologia radioterapica.
GE HealthCare (Nasdaq: GEHC) anunció sus últimas innovaciones en oncología radioterápica que se mostrarán en la conferencia de la American Society for Radiation Oncology (ASTRO) 2024. La empresa presenta varias soluciones mejoradas con IA, destinadas a mejorar el flujo de trabajo en la terapia de radiación:
1. Terapia de Radiación Inteligente (iRT): Permite la interoperabilidad y la eficiencia de sistemas de múltiples proveedores a lo largo del continuum de atención.
2. Revolution™ RT: Una plataforma CT de gran apertura para la simulación de terapia radioterápica de precisión.
3. MIM Maestro y Contour ProtégéAI+: Tecnologías interoperables para el auto-contorno con IA y una planificación del tratamiento mejorada.
4. Asistente de Volumen Prostático: Software de IA para mediciones automáticas del volumen prostático.
5. StarGuide™: Un sistema SPECT/CT digital para decisiones de atención personalizadas en Theranostics.
Estas innovaciones tienen como objetivo agilizar los flujos de trabajo, reducir el tiempo hasta el tratamiento y mejorar los resultados para los pacientes en oncología radioterápica.
GE 헬스케어(Nasdaq: GEHC)는 2024년 미국 방사선 종양학회(ASTRO) 회의에서 선보일 방사선 종양학의 최신 혁신을 발표했습니다. 이 회사는 방사선 치료 워크플로우를 개선하기 위해 AI 기반의 여러 솔루션을 선보이고 있습니다:
1. 지능형 방사선 치료(iRT): 여러 공급업체의 시스템 간 상호운용성과 효율성을 보장합니다.
2. Revolution™ RT: 정밀 방사선 치료 시뮬레이션을 위한 넓은 개구 CT 플랫폼입니다.
3. MIM Maestro와 Contour ProtégéAI+: AI 자동 컨투링 및 향상된 치료 계획을 위한 상호운용 가능한 기술입니다.
4. 전립선 부피 보조도구: 전립선 부피 측정을 자동화하는 AI 소프트웨어입니다.
5. StarGuide™: 테라노스틱스에서 개인화된 치료 결정을 위한 디지털 SPECT/CT 시스템입니다.
이러한 혁신은 워크플로우를 간소화하고 치료 시작 시간을 줄이며 방사선 종양학에서 환자 결과를 개선하는 것을 목표로 하고 있습니다.
GE HealthCare (Nasdaq: GEHC) a annoncé ses dernières innovations en oncologie radiologique qui seront présentées lors de la conférence de l’American Society for Radiation Oncology (ASTRO) 2024. L’entreprise présente plusieurs solutions améliorées par l’IA, visant à améliorer le flux de travail en radiothérapie :
1. Thérapie Radiologique Intelligente (iRT): Permet l’interopérabilité et l’efficacité des systèmes multi-fournisseurs tout au long du continuum de soins.
2. Revolution™ RT: Une plateforme CT à large ouverture pour la simulation de la thérapie radiologique de précision.
3. MIM Maestro et Contour ProtégéAI+: Technologies interopérables pour le contouring automatique par IA et une planification de traitement améliorée.
4. Assistance au Volume Prostatique: Logiciel d’IA pour des mesures automatiques du volume prostatique.
5. StarGuide™: Un système SPECT/CT numérique pour des décisions de soins personnalisées en Theranostics.
Ces innovations visent à rationaliser les processus de travail, réduire le délai de traitement et améliorer les résultats pour les patients en oncologie radiologique.
GE HealthCare (Nasdaq: GEHC) hat seine neuesten Innovationen in der Strahlenonkologie angekündigt, die auf der Konferenz der American Society for Radiation Oncology (ASTRO) 2024 vorgestellt werden. Das Unternehmen präsentiert mehrere KI-gestützte Lösungen, die darauf abzielen, den Workflow der Strahlentherapie zu verbessern:
1. Intelligente Strahlentherapie (iRT): Ermöglicht die Interoperabilität und Effizienz von Systemen mehrerer Anbieter im gesamten Versorgungsprozess.
2. Revolution™ RT: Eine große CT-Plattform für die Simulation von präziser Strahlentherapie.
3. MIM Maestro und Contour ProtégéAI+: Interoperable Technologien für KI-gestütztes automatische Konturierung und verbesserte Behandlungsplanung.
4. Prostatavolumen-Assistent: KI-Software für automatisierte Messungen des Prostatavolumens.
5. StarGuide™: Ein digitales SPECT/CT-System für personalisierte Entscheidungen in der Theranostik.
Diese Innovationen zielen darauf ab, Arbeitsabläufe zu optimieren, die Zeit bis zur Behandlung zu verkürzen und die Ergebnisse für Patienten in der Strahlenonkologie zu verbessern.
Positive
- Introduction of AI-enhanced radiation therapy solutions to improve workflow efficiency
- Potential reduction in time between simulation and first radiation dose with Instaplan feature
- Acquisition of MIM Software in April 2024, expanding GE HealthCare’s oncology portfolio
- Implementation of iRT by top healthcare institutions globally
- Hosting of educational symposiums at ASTRO 2024 to showcase new technologies
GE HealthCare (Nasdaq: GEHC) today announced its latest innovations in radiation oncology that will be showcased at the American Society for Radiation Oncology (ASTRO) 2024 conference in
It is estimated that 470,000 patients receive radiotherapy each year in the
GE HealthCare will be showcasing the following radiation oncology solutions at ASTRO 2024:
- Intelligent Radiation Therapy (iRT): Designed to enable multi-vendor system interoperability, connectivity, and efficiency throughout the radiation oncology care continuum. The artificial intelligence (AI)-enhanced iRT includes key features such as an integrated workflow that connects hardware and software vendors, as well as various applications, into an intuitive single interface.
- Revolution™ RT: Recently introduced at ESTRO, this new system enables precision radiation therapy simulation and includes a wide-bore CT (computed tomography) platform and high-performance radiation therapy simulation, diagnostic, and interventional capabilities. The technology’s capabilities are now further enhanced with GE HealthCare’s MIM Software solutions.
- MIM Maestro and Contour ProtégéAI+: A range of interoperable technologies from GE HealthCare’s MIM Software (acquired in April 2024), including Contour ProtégéAI+ for zero-click AI auto-contouring and MIM Maestro for easier reirradiation, faster simulation-to-treatment times, and better target volumes.
- Prostate Volume Assist: AI software available on ultrasound-guided active imaging systems designed to automate the process for generating prostate volume measurements.
- StarGuide™: A digital SPECT (Single Photon Emission Computed Tomography)/CT offering clinicians unique opportunities to make personalized care decisions and treatment response assessments that are at the heart of Theranostics, which combines cancer treatment with diagnostic tools that help precisely diagnose and monitor disease.
“We are innovating to solve the greatest challenges in radiation oncology and aiming to provide more complete understanding of the data that inform key clinical decisions throughout the care pathway,” says Dr. Ben Newton, GE HealthCare’s general manager for Oncology Solutions. “Our portfolio of deep learning-based interoperable solutions includes innovations that span from pre-treatment planning to post-treatment imaging, featuring AI-enhanced solutions that connect and optimize workflows to better curate and synthesize complex data and allow clinicians to focus more of their time on patient care.”
Intelligent Radiation Therapy (iRT)
Top healthcare institutions across the globe – from
At ASTRO 2024, GE HealthCare and MIM Software will be hosting two lunch symposiums, including:
- “Data-Enhanced Strategies in Improving Radiation Therapy Outcomes” on September 29 at 12pm EST in Room 154 of the Walter E. Washington Convention Center.
- “Reducing Time to Treatment with MIM Software” on October 1 at 12pm EST in Room 154 at the Walter E. Washington Convention Center.
To learn more about GE HealthCare’s oncology care solutions, please visit booth #713 (GE HealthCare) and booth #1511 (GE HealthCare’s MIM Software) or visit this ASTRO event page. GE HealthCare’s immersive experience booth will be organized around the patient care journey, emphasizing diagnosis, planning, treatment, and follow-up, as well as featuring the company’s latest advancements and ecosystem partners at each stage. In addition, GE HealthCare will host various “Meet the Experts” sessions at the booth.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a
Follow us on LinkedIn, X , Facebook, Instagram, and Insights for the latest news, or visit our website for more information.
i Deborah E. Citrin, M.D. Recent Developments in Radiotherapy. Published September 14, 2017. N Engl J Med 2017;377:1065-1075, DOI: 10.1056/NEJMra1608986 VOL. 377 NO. 11. Available at: www.nejm.org/doi/full/10.1056/NEJMra1608986. Last accessed September 2024.
View source version on businesswire.com:
GE HealthCare Media Contact
Karin Dalsin
Global Communications Director
[email protected]
+1-612-219-2855
Source: GE HealthCare
FAQ
What new radiation oncology solutions is GE HealthCare (GEHC) showcasing at ASTRO 2024?
GE HealthCare is showcasing Intelligent Radiation Therapy (iRT), Revolution™ RT, MIM Maestro and Contour ProtégéAI+, Prostate Volume Assist, and StarGuide™ at ASTRO 2024. These AI-enhanced solutions aim to improve the radiation therapy workflow for clinicians and cancer patients.
How does GE HealthCare’s Intelligent Radiation Therapy (iRT) system benefit patients?
iRT enables multi-vendor system interoperability and efficiency throughout the radiation oncology care continuum. It can potentially shorten the timeline to treatment for patients by standardizing complex workflows and managing advanced imaging and machine learning algorithms for more precise tumor targeting.
What is the Instaplan feature in GE HealthCare’s iRT solution?
Instaplan is a feature in GE HealthCare’s iRT solution that creates a treatment plan while the patient is still on the simulation table. This could potentially reduce the critical time between simulation and first radiation dose, representing a significant paradigm shift in radiation therapy planning.
When did GE HealthCare (GEHC) acquire MIM Software?
GE HealthCare acquired MIM Software in April 2024, expanding its portfolio of interoperable technologies for radiation oncology, including Contour ProtégéAI+ for zero-click AI auto-contouring and MIM Maestro for improved treatment planning.
link